In the latest session, Fortress Biotech Inc (NASDAQ: FBIO) closed at $2.00 down -7.83% from its previous closing price of $2.17. In other words, the price has decreased by -$0.1700 from its previous closing price. On the day, 311844 shares were traded.
Ratios:
For a deeper understanding of Fortress Biotech Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 4.44 whereas as Long-Term Debt/Eq ratio is at 3.88.
On August 04, 2022, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $6.
On October 02, 2020, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $9.The Benchmark Company initiated its Buy rating on October 02, 2020, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 05 ’24 when ROSENWALD LINDSAY A MD bought 50,000 shares for $2.38 per share. The transaction valued at 118,770 led to the insider holds 2,863,905 shares of the business.
ROSENWALD LINDSAY A MD bought 1,567,515 shares of FBIO for $2,664,776 on Nov 14 ’23. The President, CEO & Chairman now owns 2,597,440 shares after completing the transaction at $1.70 per share. On Nov 14 ’23, another insider, WEISS MICHAEL S, who serves as the insider of the company, bought 147,058 shares for $1.70 each. As a result, the insider paid 249,999 and bolstered with 1,130,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBIO now has a Market Capitalization of 39.69M and an Enterprise Value of 37.54M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.45 while its Price-to-Book (P/B) ratio in mrq is 0.07. Its current Enterprise Value per Revenue stands at 0.46 whereas that against EBITDA is -0.24.
Stock Price History:
Over the past 52 weeks, FBIO has reached a high of $12.75, while it has fallen to a 52-week low of $1.24. The 50-Day Moving Average of the stock is 1.9478, while the 200-Day Moving Average is calculated to be 4.2262.
Shares Statistics:
For the past three months, FBIO has traded an average of 492.39K shares per day and 347.66k over the past ten days. A total of 18.38M shares are outstanding, with a floating share count of 13.35M. Insiders hold about 27.33% of the company’s shares, while institutions hold 25.49% stake in the company. Shares short for FBIO as of Mar 15, 2024 were 1.73M with a Short Ratio of 3.52, compared to 1.64M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.42% and a Short% of Float of 10.75%.
Earnings Estimates
There are 3 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$1.97 for the current quarter, with a high estimate of -$1.49 and a low estimate of -$2.61, while EPS last year was -$4.46. The consensus estimate for the next quarter is -$1.41, with high estimates of -$1.28 and low estimates of -$1.55.
Analysts are recommending an EPS of between -$6.13 and -$9.36 for the fiscal current year, implying an average EPS of -$7.38. EPS for the following year is -$2.9, with 3 analysts recommending between -$0.4 and -$4.85.
Revenue Estimates
A total of 3 analysts believe the company’s revenue will be $14.89M this quarter.It ranges from a high estimate of $15.69M to a low estimate of $14.46M. As of the current estimate, Fortress Biotech Inc’s year-ago sales were $16.4M, an estimated decrease of -9.20% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $14.75M, an increase of 18.70% over than the figure of -$9.20% in the same quarter last year. There is a high estimate of $14.87M for the next quarter, whereas the lowest estimate is $14.63M.
A total of 3 analysts have provided revenue estimates for FBIO’s current fiscal year. The highest revenue estimate was $80.26M, while the lowest revenue estimate was $53.28M, resulting in an average revenue estimate of $70.88M. In the same quarter a year ago, actual revenue was $75.74M, down -6.40% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $74.81M in the next fiscal year. The high estimate is $98.63M and the low estimate is $61.62M. The average revenue growth estimate for next year is up 5.50% from the average revenue estimate for this year.
